HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attenuation of the stimulant response to ethanol is associated with enhanced ataxia for a GABA, but not a GABA, receptor agonist.

AbstractBACKGROUND:
The gamma-aminobutyric acid (GABA) system is implicated in the neurobiological actions of ethanol, and pharmacological agents that increase the activity of this system have been proposed as potential treatments for alcohol use disorders. As ethanol has its own GABA mimetic properties, it is critical to determine the mechanism by which GABAergic drugs may reduce the response to ethanol (i.e., via an inhibition or an accentuation of the neurobiological effects of ethanol).
METHODS:
In this study, we examined the ability of 3 different types of GABAergic compounds, the GABA reuptake inhibitor NO-711, the GABA(A) receptor agonist muscimol, and the GABA(B) receptor agonist baclofen, to attenuate the locomotor stimulant response to ethanol in FAST mice, which were selectively bred for extreme sensitivity to ethanol-induced locomotor stimulation. To determine whether these compounds produced a specific reduction in stimulation, their effects on ethanol-induced motor incoordination were also examined.
RESULTS:
NO-711, muscimol, and baclofen were all found to potently attenuate the locomotor stimulant response to ethanol in FAST mice. However, both NO-711 and muscimol markedly increased ethanol-induced ataxia, whereas baclofen did not accentuate this response.
CONCLUSIONS:
These results suggest that pharmacological agents that increase extracellular concentrations of GABA and GABA(A) receptor activity may attenuate the stimulant effects of ethanol by accentuating its intoxicating and sedative properties. However, selective activation of the GABA(B) receptor appears to produce a specific attenuation of ethanol-induced stimulation, suggesting that GABA(B) receptor agonists may hold greater promise as potential pharmacotherapies for alcohol use disorders.
AuthorsSarah E Holstein, Lauren Dobbs, Tamara J Phillips
JournalAlcoholism, clinical and experimental research (Alcohol Clin Exp Res) Vol. 33 Issue 1 Pg. 108-20 (Jan 2009) ISSN: 1530-0277 [Electronic] England
PMID18945218 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • GABA-A Receptor Agonists
  • GABA-B Receptor Agonists
  • Nipecotic Acids
  • Oximes
  • Receptors, GABA-A
  • Receptors, GABA-B
  • NNC 711
  • Muscimol
  • Ethanol
  • Baclofen
Topics
  • Animals
  • Ataxia (chemically induced, metabolism, physiopathology)
  • Baclofen (pharmacology)
  • Dose-Response Relationship, Drug
  • Ethanol (antagonists & inhibitors, toxicity)
  • GABA-A Receptor Agonists
  • GABA-B Receptor Agonists
  • Male
  • Mice
  • Mice, Mutant Strains
  • Motor Activity (drug effects, physiology)
  • Muscimol (pharmacology)
  • Nipecotic Acids (pharmacology)
  • Oximes (pharmacology)
  • Receptors, GABA-A (metabolism)
  • Receptors, GABA-B (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: